Document is current
Any future updates will be listed below
-
Authors
Aebischer, Vera https://orcid.org/0009-0005-1066-9773
Brehm, Alex https://orcid.org/0000-0002-1630-6210
Rommers, Nikki https://orcid.org/0000-0003-0311-5009
Spiotta, Alejandro https://orcid.org/0000-0002-7142-5538
Sowlat, Mohammad https://orcid.org/0000-0001-6777-4332
Raghuram, Karthik https://orcid.org/0000-0003-2995-2913
Cappuzzo, Justin M. https://orcid.org/0000-0002-5794-3339
Beecher, Jeffrey
Matouk, Charles https://orcid.org/0000-0003-3234-9541
Amllay, Abdelaziz https://orcid.org/0000-0003-3357-4134
Rohr, Axel https://orcid.org/0000-0003-4684-7920
Heran, Manraj https://orcid.org/0000-0003-0040-6054
Volders, David https://orcid.org/0000-0003-4074-8702
Mosimann, Pascal J. https://orcid.org/0000-0001-5111-1972
Al-Tibi, Mohammad https://orcid.org/0000-0002-3589-2526
Wassélius, Johan https://orcid.org/0000-0003-1896-381X
Hansen, Björn M. https://orcid.org/0000-0001-8661-9063
Holtmannspötter, Markus https://orcid.org/0000-0003-2536-5244
Schlösser, Martin
Meckel, Stephan https://orcid.org/0000-0001-6468-4526
Aoua, Oumaima https://orcid.org/0009-0006-9717-0779
Giragani, Suresh https://orcid.org/0000-0002-5177-0473
Boghi, Andrea https://orcid.org/0000-0003-1729-4036
Ntoulias, Nikolaos https://orcid.org/0000-0003-2886-3468
Schulze-Zachau, Victor https://orcid.org/0000-0003-0945-8379
Tsogkas, Ioannis https://orcid.org/0000-0003-2561-9603
Blackham, Kristine A. https://orcid.org/0000-0002-1620-1144
Anastasiou, Aikaterini https://orcid.org/0000-0002-5405-4237
Psychogios, Marios https://orcid.org/0000-0002-0016-414X
-
Funding
Funding for this research was provided by:
University of Basel
- License Information
-
More Information
Article History
Received: 30 April 2025
Accepted: 8 September 2025
First Online: 29 September 2025
Declarations
:
: A. Spiotta: Consultant for Penumbra, Terumo and Cerenovus. J.M. Cappuzzo: Honorarium for Training from and Consultant for Medtronic, Penumbra, Q’Apel Medical Inc.. J. Beecher: Consultant for Penumbra, Medtronic, Providence Medical, Aesculap Surgical Equipment. C. Matouk: Consultant for Penumbra, Terumo Neurovascular, Silk Road Medical and has stock options of CereVasc and Jiva Medical. D. Volders: Consultant for Penumbra. J. Wassélius: Founder and shareholder of Uman Sense AB, Speaker fees from Siemens Healthineers, Balt Group and Medtronic. M. Heran: Speaker fees from Penumbra, Siemens and Sim&Cure, Consultant for Balt, Stryker, Microvention, Phenox and Medtronic and is Advisory Board member of Oruen. M. Schlösser: Consultant for Balt, Speaker fees from Penumbra. S. Meckel: Consultant for Acandis, Balt and Medtronic, Speaker fees from Balt, Medtronic, Penumbra and is member of the scientific advisory board “TitAIN Imaging AdBoard”. V. Schulze-Zachau: Speaker fees from Medtronic and Grants from Bangerter-Rhyner Foundation and Freiwillige Akademische Gesellschaft Basel. M. Psychogios: Grants from the Swiss National Science Foundation (SNF) for the DISTAL trial (33IC30_198783), ICARUS (32003B_220118) and TECNO trial (32003B_204977), Grant from Bangerter-Rhyner Foundation for the DISTAL trial. Unrestricted Grants for the DISTAL trial from Stryker Neurovascular Inc., Medtronic Inc., Phenox GmbH, Penumbra Inc. and Rapid Medical Inc., Sponsor-PI SPINNERS trial (funded by a Siemens Healthineers AG Grant), Research agreement with Siemens Healthineers AG, Local PI for the ASSIST, EXCELLENT, TENSION, COATING, SURF and ESCAPE-NEXT trials, Speaker fees from Stryker Neurovascular Inc., Medtronic Inc., Penumbra Inc., Acandis GmbH, Phenox GmbH, Siemens Healthineers AG. V. Aebischer, A. Brehm, N. Rommers, M. Sowlat, K. Raghuram, A. Amllay, A. Rohr, P.J. Mosimann, M. Al-Tibi, B.M. Hansen, M. Holtmannspötter, O. Aoua, S. Giragani, A. Boghi, N. Ntoulias, I. Tsogkas, K.A. Blackham and A. Anastasiou declare that they have no competing interests.
: This study was approved by the ethics committee and is registered with the Project-ID 2025-00139 at Ethics Committee Northwest and Central Switzerland.
